Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
It is fitting that an early hours statement, made on Monday July 29, could draw to a close an acrimonious five-month battle often played out via outbursts published first thing in the morning. The announcement made public an agreed deal by Perrigo, a US over-the-counter pharmaceutical specialist, for Irish biotechnology company Elan, which heralds the conclusion of a lengthy process involving no fewer than 12 advisers and lending banks and described by those close to the deal as ugly, aggressive and bruising. One of the advisers involved said: “It is certainly right at the end of the hostile scale.
Help employers find you! Check out all the jobs and post your resume.
It is fitting that an early hours statement, made on Monday July 29, could draw to a close an acrimonious five-month battle often played out via outbursts published first thing in the morning. The announcement made public an agreed deal by Perrigo, a US over-the-counter pharmaceutical specialist, for Irish biotechnology company Elan, which heralds the conclusion of a lengthy process involving no fewer than 12 advisers and lending banks and described by those close to the deal as ugly, aggressive and bruising. One of the advisers involved said: “It is certainly right at the end of the hostile scale.
Help employers find you! Check out all the jobs and post your resume.
